Flaminia Frascarelli

Dr. Flaminia Frascarelli


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of NeuroEngineering and Rehabilitation
Verified
Journal Article
Open access
PDF file
LMLorenzo Masia
Lorenzo Masia
FFFlaminia Frascarelli
Flaminia Frascarelli
PMPietro Morasso
Pietro Morasso
GRGiuseppe Di Rosa
Giuseppe Di Rosa
MPMaurizio Petrarca
Maurizio Petrarca
PCPaolo Cappa
Paolo Cappa
It is known that healthy adults can quickly adapt to a novel dynamic environment, generated by a robotic manipulandum as a structured disturbing force field. We suggest that it may be of clinical interest to evaluate to which extent this kind of motor learning capability is impaired in children affected by cerebal palsy.

1 January 2011 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
FFFlaminia Frascarelli
Flaminia Frascarelli
GRGiuseppe Di Rosa
Giuseppe Di Rosa
EBEleonora Bisozzi
Eleonora Bisozzi
ECEnrico Castelli
Enrico Castelli
VSValter Santilli
Valter Santilli

18 April 2024 in Genes
Verified
Journal Article
Open access
PDF file
JSJacopo Sartorelli
Jacopo Sartorelli
LTLorena Travaglini
Lorena Travaglini
MMMarina Macchiaiolo
Marina Macchiaiolo
GGGiacomo Garone
Giacomo Garone
MGMichaela Veronika Gonfiantini
Michaela Veronika Gonfiantini
Francesco NicitaFrancesco Nicita
Francesco Nicita
(1) Background: Cockayne syndrome (CS) is an ultra-rare multisystem disorder, classically subdivided into three forms and characterized by a clinical spectrum without a clear genotype-phenotype correlation for both the two causative genes ERCC6 (CS type B) and ERCC8 (CS type A). We assessed this, presenting a series of patients with genetically confirmed CSB. (2) Materials and Methods: We retrospectively collected demographic, clinical, genetic, neuroimaging, and serum neurofilament light-chain (sNFL) data about CSB patients; diagnostic and severity scores were also determined. (3) Results: Data of eight ERCC6/CSB patients are presented. Four patients had CS I, three patients CS II, and one patient CS III. Various degrees of ataxia and spasticity were cardinal neurologic features, with variably combined systemic characteristics. Mean age at diagnosis was lower in the type II form, in which classic CS signs were more evident. Interestingly, sNFL determination appeared to reflect clinical classification. Two novel premature stop codon and one novel missense variants were identified. All CS I subjects harbored the p.Arg735Ter variant; the milder CS III subject carried the p.Leu764Ser missense change. (4) Conclusion: Our work confirms clinical variability also in the ERCC6/CSB type, where manifestations may range from severe involvement with prenatal or neonatal onset to normal psychomotor development followed by progressive ataxia. We propose, for the first time in CS, sNFL as a useful peripheral biomarker, with increased levels compared to currently available reference values and with the potential ability to reflect disease severity.

30 November 2009 in Gait & Posture
Verified
Journal Article
Closed access
MPMaurizio Petrarca
Maurizio Petrarca
GZGiulia Zanelli
Giulia Zanelli
FPFabrizio Patane
Fabrizio Patane
FFFlaminia Frascarelli
Flaminia Frascarelli
JJJennifer L. Jackson
Jennifer L. Jackson
ECEnrico Castelli
Enrico Castelli